BackHalozyme Therapeutics Overview
Halozyme Therapeutics Inc.

Halozyme Therapeutics Target Price

Analysts' 12-month price predictions for HALO.

Share Price

$57.9

Average Target Price

$52.0010.2% downside

1 analysts in the last 4 months

High: $52 | Low: $52

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2024-11-15Piper SandlerJoseph Catanzaro$5210.2% downsideOpen
2024-06-07H.C. WainwrightMitchell Kapoor$6512.3% upsideOpen
2024-06-07Piper SandlerJoseph Catanzaro$5111.9% downsideOpen
2024-06-07Wells FargoMohit Bansal$580.2% upsideOpen
2024-06-06Goldman SachsCorinne Jenkins$4424% downsideOpen
2023-01-11Leerink Partners$615.4% upsideOpen
2022-12-21Morgan Stanley$6512.3% upsideOpen
2022-11-28Wells Fargo$6512.3% upsideOpen
2022-11-22J.P. Morgan$546.7% downsideOpen